2017 | Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
| WORLD JOURNAL OF GASTROENTEROLOGY |
2011 | Multidisciplinary management of nonresectable hepatocellular carcinoma | ONCOLOGY |
2014 | Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma | LIVER CANCER |
2014 | Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma. | ONCOLOGY |
2014 | Multimodality treatment with radiotherapy for huge hepatocellular carcinoma. | ONCOLOGY |
2014 | Neonatal capsaicin treatment in rats affects TRPV1-related noxious heat sensation and circadian body temperature rhythm | JOURNAL OF THE NEUROLOGICAL SCIENCES |
2019 | Noninvasive Biomarker for Predicting Treatment Response to Concurrent Chemoradiotherapy in Patients with Hepatocellular Carcinoma
| Investigative Magnetic Resonance Imaging |
2006 | Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Curative Resection With Tumor-Specific Mesorectal Excision for Fixed Locally Advanced Rectal Cancer: Impact of Postirradiated Pathologic Downstaging on Local Recurrence and Survival | ANNALS OF SURGERY |
2013 | Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy
| JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE |
2016 | Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma
| LIVER CANCER |
2021 | Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
2014 | Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
| JOURNAL OF RADIATION RESEARCH |
2012 | Pancreatoduodenectomy following neoadjuvant chemoradiation therapy in uncinate process pancreatic cancer. | PANCREAS |
2015 | Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
| MEDICINE |
2022 | Pattern and clinical significance of lymph node metastasis from hepatocellular carcinoma | JOURNAL OF CLINICAL ONCOLOGY |
2003 | Patterns of Care 연구 개발을 위한 직장암의 수술 후 방사선치료 시 적정 방사선치료 조사영역 제안
| Journal of the Korean Society for Therapeutic Radiology and Oncology |
2009 | Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy | RADIOLOGY |
2016 | Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
| ONCOTARGET |
2019 | Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma | DIGESTIVE AND LIVER DISEASE |
2009 | Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
2018 | Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2009 | Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2014 | Postoperative radiotherapy dose correlates with locoregional control in patients with locoregional control in patients with extra-hepatic bile duct cancer
| RADIATION ONCOLOGY JOURNAL |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
1997 | Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha | ANTI-CANCER DRUGS |
2015 | Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma
| GUT AND LIVER |
2001 | Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2009 | Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection | LANGENBECKS ARCHIVES OF SURGERY |
2020 | Prognostic factors and patterns of loco-regional failure in patients with R0 resected gallbladder cancer | HPB |
2017 | Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02)
| ONCOTARGET |
2014 | Prognostic Values of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 in Hepatocellular Carcinoma after Radiotherapy | DIGESTIVE DISEASES |
2006 | Proteomics Analysis of Apoptosis-regulating Proteins in Tissues with Different Radiosensitivity
| JOURNAL OF RADIATION RESEARCH |
2004 | Proteomics를 이용한 마우스 조직에서의 방사선 감수성 조절 단백질의 탐색
| Journal of the Korean Society for Therapeutic Radiology and Oncology |
2017 | Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model
| ONCOTARGET |
2016 | Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells.
| PLOS ONE |
2004 | Radiation-induced alteration of pain-related signals in an animal model with bone invasion from cancer | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES |
2019 | Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma
| Molecules and Cells |
2007 | Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma | HEPATOLOGY RESEARCH |
2016 | Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Radiosensitizers in hepatocellular carcinoma | SEMINARS IN RADIATION ONCOLOGY |
2014 | Radiotherapeutic Options for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| LIVER CANCER |
2009 | Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2017 | Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area | LIVER INTERNATIONAL |
2011 | Radiotherapeutic strategies in the management of hepatocellular carcinoma | ONCOLOGY |
2021 | Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
| WORLD JOURNAL OF GASTROENTEROLOGY |
2008 | Radiotherapy for hepatocellular carcinoma: an overview. | ANNALS OF SURGICAL ONCOLOGY |
2005 | Radiotherapy for painful bone metastases from hepatocellular carcinoma | LIVER INTERNATIONAL |
2016 | Re-Irradiation of Hepatocellular Carcinoma: Clinical Applicability of Deformable Image Registration
| YONSEI MEDICAL JOURNAL |
2019 | Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta-analyses | JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY |
2010 | Recombinant human epidermal growth factor (rhEGF) protects radiation-induced intestine injury in murine system
| JOURNAL OF RADIATION RESEARCH |
2004 | Redox Signaling by Ionizing Radiation in Mouse Liver | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES |
2012 | Reirradiation to the pelvis for recurrent rectal cancer | JOURNAL OF SURGICAL ONCOLOGY |
2020 | Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?" | JOURNAL OF HEPATOLOGY |
2020 | Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers | JOURNAL OF HEPATOLOGY |
2017 | Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT? | LIVER INTERNATIONAL |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
2017 | Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and 18F-fluoro-2-deoxyglucose positron emission tomography | LIVER INTERNATIONAL |